Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia

被引：38

作者：

Rosenblum, MD ^{[1
]}

LaBelle, JL ^{[1
]}

Chang, CC ^{[1
]}

Margolis, DA ^{[1
]}

Schauer, DW ^{[1
]}

Vesole, DH ^{[1
]}

机构：

[1] Med Coll Wisconsin, Dept Med, Div Neoplast Dis & Related Disorders, Milwaukee, WI 53226 USA

来源：

BLOOD | 2004年 / 103卷 / 05期

关键词：

D O I：

10.1182/blood-2003-11-3951

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1969 / 1971

页数：3

相关论文

共 6 条

[1] Campath-1H monoclonal antibody therapy
Flynn, JM
Byrd, JC
[J]. CURRENT OPINION IN ONCOLOGY, 2000, 12 (06) : 574 - 581
[2] Levels of expression of CD52 in normal and leukemic B and T cells:: Correlation with in vivo therapeutic responses to Campath-1H
Ginaldi, L
De Martinis, M
Matutes, E
Farahat, N
Morilla, R
Dyer, MJS
Catovsky, D
[J]. LEUKEMIA RESEARCH, 1998, 22 (02) : 185 - 191
[3] HARRIS NL, 1994, BLOOD, V84, P1361
[4] Clinical features of large granular lymphocyte leukemia
Lamy, T
Loughran, TP
[J]. SEMINARS IN HEMATOLOGY, 2003, 40 (03) : 185 - 195
[5] Large granular lymphocytic leukemia: An overview
Loughran, TP
[J]. HOSPITAL PRACTICE, 1998, 33 (05) : 133 - +
[6] LOUGHRAN TP, 1994, BLOOD, V84, P2164